Abbreviations & Acronyms ATP3 = Third Adult Treatment Panel BMI = body mass index BPH = benign prostate hyperplasia CI = confidence interval DRE = digital rectal examination IL = interleukin LUTS = lower urinary tract symptoms MetS = metabolic syndrome NVB = neurovascular bundles OR = odds ratio PSA = prostate-specific antigen RARP = robot-assisted radical prostatectomy RP = radical prostatectomy SD = standard deviation TNF = tumor necrosis factor Objectives: To evaluate the impact of metabolic syndrome on the early recovery of urinary continence after robot-assisted radical prostatectomy. Methods: The present study included a total of 302 consecutive Japanese patients with clinically localized prostate cancer who underwent robot-assisted radical prostatectomy. In this study, postoperative urinary continence was defined as no leak or the use of a security pad. The continence status was assessed by interviews before and 1 and 3 months after robot-assisted radical prostatectomy. Metabolic syndrome was defined as follows: body mass index ≥25 kg/m 2 and two or more of the following: hypertension, diabetes mellitus and dyslipidemia. The effect of the presence of metabolic syndrome on the continence status of these patients was retrospectively examined. Results: A total of 116 (38.4%) and 203 (67.2%) of the 302 patients were continent at 1 and 3 months after robot-assisted radical prostatectomy, respectively. A total of 31 (10.3%) patients were judged to have metabolic syndrome. Despite the operative time being longer in patients with metabolic syndrome, no significant differences were observed in the remaining preoperative, intraoperative or postoperative variables between patients with or without metabolic syndrome. On multivariate logistic regression analysis, metabolic syndrome and the duration of hospitalization were significantly correlated with the 1-month continence status. Similarly, metabolic syndrome and estimated blood loss during surgery were independent predictors of continence rates at 3 months after robot-assisted radical prostatectomy. Conclusions: These findings suggest that the presence of metabolic syndrome could have a significant impact on the early recovery of urinary continence after robot-assisted radical prostatectomy.
Introduction
RP is the mainstay of curative therapy for men with localized prostate cancer. Since its introduction in 1999, RARP has rapidly become the dominant technique for surgical treatment, and mounting evidence shows that RARP compares favorably with open radical or laparoscopic prostatectomy in terms of perioperative complications and postoperative functional results. 1 Despite progress in the fields of pelvic anatomy and surgical techniques, 2 urinary incontinence remains a notable complication after RP. 3 Although urinary incontinence after RP is mainly attributed to sphincteric deficiency as a result of intraoperative injury, 4 and the physiology of the mechanisms of continence after RP is still not fully understood, various studies have suggested patient risk factors, such as age, obesity, prostate size, membranous urethral length and the presence of comorbidities, being associated with recovery from postoperative urinary continence. men. 10 To our knowledge, however, no study has been reported with respect to the correlation between the presence of MetS and postoperative continence status in Japanese patients undergoing RP.
Considering these findings, we retrospectively analyzed the effect of MetS on the early recovery of urinary continence in a total of 302 consecutive patients with prostate cancer who underwent RARP.
Methods
The present study included 302 consecutive Japanese patients who were diagnosed with clinically localized prostate cancer and subsequently underwent RARP between April 2012 and March 2016 at Seirei Mikatabara Hospital, Hamamatsu, Japan. Of the 302 patients, 42 (13.9%) were treated with anti-androgen therapy, whereas none of these patients underwent anti-androgen therapy or radiation therapy after surgery. The study design was approved by the research ethics committee of our institution, and informed consent for carrying out the present study was obtained from all of the included patients. Clinicopathological information on these patients was retrieved from their medical records. Collected data included the following preoperative variables: age, serum PSA at diagnosis, DRE, Gleason score at biopsy, D'Amico risk group and history of abdominal surgery; and MetS was defined as follows: BMI ≥25 kg/m 2 and two or more of the following: hypertension, diabetes mellitus and dyslipidemia. 11, 12 Intraoperative and postoperative variables were also obtained: estimated blood loss, skin-to-skin and console operative time, the status of preservation of the neurovascular bundles, duration of catheterization and hospitalization, prostate weight, pathological tumor stage, Gleason score at the final diagnosis, and surgical margin status. In our institution, pelvic lymph node dissection was routinely carried out in all cases. In the present study, postoperative urinary continence was defined as no leak or the use of a security pad, and the continence status was assessed by interviews before and 1 and 3 months after RARP.
In the present study, two surgeons carried out 302 RARP procedures (A: 207 and B: 95; initial 10 surgeries were excluded from this study, respectively). RARP was carried out using a four-arm da Vinci robotic system (Intuitive Surgical, Sunnyvale, CA, USA) using a transperitoneal approach in accordance with a previous report. 13 Briefly, after the prostatic peri-fatty tissue was removed, the endopelvic fascia was incised bilaterally. Before ligating the prostatic vascular pedicles, bladder neck dissection and mobilization of the seminal vesicles were carried out. The dorsal vein complex and urethra were incised without thermal energy using robotic scissors. Preservation of the neurovascular bundles through interfascial dissection was indicated considering the localization of tumor lesions in the prostate based on the preoperative magnetic resonance imaging and/or DRE findings. Posterior reconstruction of the rhabdomyosphincter with anterior suspension was usually carried out, and vesicourethral anastomosis was carried out as previously described. 14 All statistical analyses were carried out using Statview 5.0 software (Abacus Concepts, Berkeley, CA, USA), and P-values <0.05 were considered significant. Differences in several parameters between the presence of MetS were compared using an unpaired t-test or v 2 -test. Logistic regression analyses were used to evaluate the association between several parameters and the urinary continence status after RARP.
Results
In the present study, all patients were continent before RARP, and 116 (38.4%) and 203 (67.2%) of the 302 patients were continent at 1 and 3 months after RARP, respectively. According to the MetS criteria, 31 (10.3%) were judged to have MetS before surgery. The mean estimated blood loss during surgery was 153.9 AE 270.2 mL. The mean skin-toskin and console operative time were 245.0 AE 64.2 min and 190.0 AE 57.5 min, respectively. A bilateral, intrafascial nerve-sparing technique was carried out in 24 patients (7.9%), a unilateral nerve-sparing technique was carried out in 128 patients (42.4%), while non-nerve-sparing RARP was carried out in 150 patients (49.7%). The median catheterization time was 5 days, and the median hospitalization was 7 days. The mean prostate weight was 41.1 AE 13.3 g.
A comparison of several factors according to the presence of MetS is shown in Table 2 . Skin-to-skin and console operative times were significantly longer in patients with MetS than without MetS; however, there were no significant differences in the remaining preoperative, intraoperative, or postoperative parameters between with and without MetS.
The impact of several factors as predictors of postoperative urinary continence was then evaluated. As shown in Table 3 , uni-and multivariate analyses identified the presence of MetS and a longer hospitalization as independent predictors of a poorer continence status at 1 month after RARP. At 3 months, MetS, in addition to estimated blood loss during surgery, also had a significant impact on the recovery of urinary continence after RARP on uni-and multivariate analyses.
Discussion
RARP has recently become a safe and feasible treatment option for men with prostate cancer in comparison with open or laparoscopic RP, as the application of robotic technologies has been shown to provide surgeons with certain inherent advantages to carry out RP with precise techniques that help preserve key anatomical structures that are involved in urinary continence. 15 As many studies have clarified, 1,15 Ficarra et al. reported that continence outcomes after RARP were superior to those after traditional surgical methods; however, it is still difficult to achieve a satisfactory continence status even after RARP, particularly regarding the early recovery of urinary continence after surgery. 3, 16 The presence of urinary incontinence after RP can significantly impair a patient's quality of life; 17 therefore, various studies have tried to identify preoperative, intraoperative and postoperative parameters that significantly affect the continence status after RARP. 3 In the preoperative setting, this information can help with patient counseling by offering a more accurate and individualized prediction of the expected results. As for preoperative parameters, various parameters including the age, Eastern Cooperative Oncology Group performance status, obesity and membranous urethral length were identified as possible predictors of early continence. [18] [19] [20] MetS was initially defined as the presence of three conditions of high blood pressure, high blood glucose and gout disease by Kylin in 1920 and, in 1988, Reaven proposed insulin resistance as a major feature of this complex medical disorder and called it X syndrome. 21 To date, several definitions have been proposed for MetS; however, the most common definition is the ATP3, the diagnosis of that is confirmed based on at least three of the four symptoms of hypertension -raised fasting plasma glucose, high triglycerides and low high-density lipoprotein cholesterol. 11 Although the prevalence of MetS varies from 10 to 84% depending on the sex, age, race and ethnicity, 40% of the population in the USA and nearly 30% in Europe have MetS and, in Japan as well, the prevalence of MetS in Japanese residents has steadily increased, reaching 10-20%. 22 In recent years, numerous studies linked Mets and several types of malignant neoplasms including prostate cancer. 9, 23 In addition, the potential association between MetS and urinary incontinence has been reported. 10, 24 To the best of our knowledge, however, the correlation between MetS and postoperative urinary continence after RP has not been investigated in Asia; therefore, in the present study, we retrospectively assessed the impact of MetS on the early recovery of urinary continence in a total of 302 consecutive Japanese patients with clinically localized prostate cancer undergoing RARP.
In the present study, 116 (38.4%) and 203 (67.2%) of 302 patients were continent at 1 and 3 months after RARP, respectively. According to the definition of possessing the components of MetS, 31 patients (10.3%) were judged to have MetS before surgery. This proportion of patients with MetS is comparable with those in previous studies. 22 As shown in Table 2 , operative times were significantly longer in the patients with MetS; however, no marked differences were observed in the preoperative, intraoperative and postoperative variables between with or without MetS. We then carried out uni-and multivariate logistic regression analyses in order to examine the impacts of MetS on the early recovery of urinary continence after RARP, and they showed that MetS is an independent predictive factor of the continence status at both 1 and 3 months after surgery. To date, many previous studies have found that several factors including patient age, BPH and obesity can be associated with urinary continence status after RP, 5,7 whereas Kwon et al. suggested that patients with MetS in the USA had comparable functional outcomes to those without MetS. 24 They defined obesity as BMI ≥30 kg/m 2 ; however, just two patients (0.6%) had a BMI of ≥30 kg/m 2 in the present study, suggesting that it might be difficult to apply the results from Western countries with regard to the correlation between some of clinical factors and urinary continence after RP to Japanese entire cohorts.
It is of interest to consider the theoretical explanation for the independent impact of MetS on postoperative urinary continence after RARP. To date, there have been various studies suggesting that MetS is associated with higher circulating concentrations of inflammation-related markers, such as IL-1, IL-6, IL-8 and TNF-a. 25 In the prostate as well, these pro-inflammatory cytokines play a crucial role in a wide variety of pathophysical phenomena. 9, 10, [26] [27] [28] [29] [30] For example, Okamoto et al. found that IL-6 functions as a paracrine growth factor for androgen-sensitive prostate cancer cells, and as an autocrine growth factor for androgen-insensitive prostate cancer cell lines, but that IL-6 has no stimulatory effect on epithelial cells derived from BPH. 26 In contrast, a higher IL-8 level was reported in the expressed prostatic secretions of subjects with BPH and chronic prostatitis. 27 Meanwhile, Juan et al. showed that transforming growth factor-b1, one of the inflammatory and fibrosis markers, was significantly increased 6 months after the surgical induction of an overactive bladder in a rat model, 28 whereas chronic inflammation was shown to induce fibrotic changes in periurethral prostate tissues from RP. 29 Fibrosis in this region has been suggested to promote urethral stiffness and LUTS. 10 More recently, Momozono et al. reported that periurethral inflammation evaluated by TNF-a expression in RARP specimens was well correlated with the urethral fibrotic change and can be a useful predictive marker of the continence status early after surgery, suggesting that urethral fibrosis as a result of inflammation could be a demographic risk factor for incontinence after RARP. 30 Although it is difficult to clearly explain the present results, MetS-induced inflammation might have a negative impact on the continence status through the development of urethral fibrosis. This hypothesis could explain, at least in part, why the presence of MetS had a significant impact on the early recovery of urinary continence after RARP.
The present study had some limitations. First, this was a retrospective study, and a sample size of just 302 patients for such a common disease as prostate cancer is insufficient; hence, further analysis with larger cohorts is required to evaluate the impact of MetS on the postoperative continence status. Second, although modified ATP3 was used, which is one of the most common definitions for the diagnosis of MetS in Japan, there are a variety of definitions of the criteria for identifying patients with MetS. 11, 12 In addition, we used BMI rather than the waist circumference as inclusion criteria for MetS. BMI is a common marker for overall obesity; however, it does not differentiate between fat and the fat-free mass. Third, the definition of postoperative urinary continence has remained variable in studies, and a huge gap between the two analyzed groups (31 with MetS vs 271 without MetS) would reduce the value of the current outcomes. In addition, the present study failed to assess several important factors, such as detrusor overactivity, which will influence continence status. Because of these limitations, it is difficult to draw definitive conclusions regarding the association between MetS and postoperative continence. Finally, despite being a potentially important issue, we assessed the effects of MetS on the continence status early after surgery alone; therefore, the present results are not applicable for the prediction of long-term incontinence, which is the most feared side-effect of RP, and the impact of medical interventions for MetS on postoperative continence is unclear because of the lack of data.
In conclusion, this is the first study to evaluate the effect of the presence of MetS on the continence status of Japanese patients after RARP. In a preoperative setting, the presence of MetS might need to be validated as a potential predictive factor of the continence status of patients with prostate cancer undergoing RARP in order to help with patient counseling by offering a more precise and individualized prediction of the expected results.
